Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ DLL4 (delta-like 4) Monoclonal Antibody (MHD4-46)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA528625
Description
This antibody recognizes the extracellular domain of DLL4 (Delta-like ligand 4), a type I transmembrane protein which plays an important role in vascular development. Functional Application: Blocking.
Delta-like ligand 4 (DLL4), also know as Delta-4, is a homologue of the Drosophila delta protein, and functions as a transmembrane bound ligand to the notch receptor Notch1. DLL4 is expressed in the vasculature and plays a critical role in vascular development. It is induced by vascular endothelial growth factor (VEGF), as a negative feedback regulator to regulate angiogenic sprouting and promote the formulation of a differentiated vascular network. DLL4 has been found to be strongly expressed in tumor vessels of clear-cell renal tumors and bladder cancer, and inhibition of DLL4 results in increased vascular proliferation but defective maturation. This in turn leads to a decrease in tumor growth, with no apparent toxicity.
Specifications
DLL4 (delta-like 4) | |
Monoclonal | |
1 mg/mL | |
PBS with no preservative; pH 7.4 | |
Q9NR61 | |
Dll4 | |
recombinant soluble human DLL4. | |
100 μg | |
Primary | |
Human | |
Antibody | |
IgG1 κ |
Flow Cytometry, Functional Assay | |
MHD4-46 | |
Unconjugated | |
Dll4 | |
AOS6; delta 4; delta ligand 4; delta like canonical Notch ligand 4; Delta4; delta-like 4 (Drosophila); delta-like 4 homolog; delta-like 4 protein; delta-like protein 4; DLL4; Drosophila Delta homolog 4; hdelta2; MGC126344; notch ligand delta-2; notch ligand DLL4; UNQ1895/PRO4341 | |
Mouse | |
Protein A | |
RUO | |
54567 | |
4°C, do not freeze | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction